Fundraising Fox
Philogen
Not specified, CH · 1 known investors
Find your way into Philogen
Sign up to see every warm intro you have to Philogen
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Philogen team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Philogen discovers and develops targeted anti-cancer biopharmaceutical drugs using monoclonal antibodies and small molecules for tumor-specific delivery. The company focuses on vascular targeting to deliver therapeutic agents to tumors while sparing healthy tissues.
Investors · 1
Funding
SEC filings, press & company announcements$70M disclosed across 1 round · 2019
- $70MraisedMay 2019 · 5 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Philogen do?
- Philogen discovers and develops targeted anti-cancer biopharmaceutical drugs using monoclonal antibodies and small molecules for tumor-specific delivery. The company focuses on vascular targeting to deliver therapeutic agents to tumors while sparing healthy tissues.
- Who are Philogen's investors?
- Philogen's investors include NovaCapital.
- How much funding has Philogen raised?
- Philogen has disclosed $70M raised across 1 round.
- Where is Philogen headquartered?
- Philogen is headquartered in Not specified, CH.